- 2019
-
Press releases - 13.02.2019
A nanomedicine which relieves pain without the risk of addiction
A painkiller nanomedicine has just been developed by Patrick Couvreur’s team at Institut Galien Paris-Sud (Université Paris-Sud/CNRS). This new drug specifically targets the area of painful inflammation without causing the addiction phenomena of current medication.
-
Press releases - 12.02.2019
Direct-acting antivirals: confirmation of their short-term clinical efficacy in “real life”
A study published in The Lanceton 11 february 2019shows that direct-acting antivirals have short-term clinical benefits in the treatment of hepatitisCvirusinfection. These results come from ANRS-funded interdisciplinary research conducted byclinicians,hepatologists, and epidemiologistsof theInserm, SorbonneUniversityand AP-HPandcoordinatedby ProfessorsFabrice CarratandStanislas Pol,and Dr Hélène Fontaine,1in9895 patientsof the ANRS CO 22 HEPATHERnational cohortrecruitedin 32 centers in France.
-
Press releases - 06.02.2019
Early Environmental Exposures and Child Respiratory Health: the Exposome Reveals its Preliminary Results
A team of researchers from Inserm, CNRS, Université Grenoble Alpes and Barcelona Institute for Global Health has shown that prenatal and postnatal exposure to various chemical pollutants is linked to decreased respiratory function in children. These results, based on the concept of the exposome (defined as the totality of an individual’s environmental exposures from conception until old age), were obtained as part of the European HELIX project and have been published in The Lancet Planetary Health.
-
Press releases - 24.01.2019
When HIV Uses Camouflage to Evade the Immune System
How is HIV able to escape the surveillance of the immune system within the very cells it infects? Researchers from Inserm, CNRS, Université de Montpellier and Université de Lorraine decided to take a closer look at one of these evasion mechanisms. They were able to observe the ability of HIV to “camouflage” its RNA within the infected cell using an intracellular enzyme. This research, published in Nature, provides new knowledge on the evasion mechanisms of HIV in the face of the innate immune system.
-
Press releases - 22.01.2019
Miniaturized Chemical Sensors to Monitor Brain Function
A team of Inserm and CNRS researchers has succeeded in developing new-generation chemical sensors to monitor the brain’s metabolism, particularly during stroke, trauma or epileptic seizure. Measuring less than 15 µm in diameter, these minimally-invasive tools monitor what is happening in the brain in order to obtain data that are much more reliable and representative of the neurochemical exchanges. This research has been published in ACS Central Science.
-
Press releases - 11.01.2019
Clarifications by Inserm following the fraud allegations surrounding the age of Jeanne Calment
In the wake of the fraud allegations surrounding the age of Jeanne Calment which have received widespread mass media and social media coverage, Inserm as a leading life sciences and health research organization wishes to make clear the following:
-
What's on? - 11.01.2019
Clarifications by Inserm following the fraud allegations surrounding the age of Jeanne Calment
In the wake of the fraud allegations surrounding the age of Jeanne Calment which have received widespread mass media and social media coverage, Inserm as a leading life sciences and health research organization wishes to make clear the following: – In 1998, following two years of research, Doctor Michel Allard from Fondation Ipsen and Jean-Marie […]
-
Press releases - 11.01.2019
Alzheimer’s: identification of potential target protein aggregates for treating the disease
La propagation des agrégats de la protéine Tau dans le cerveau contribue à la progression de la maladie d’Alzheimer. Des chercheurs du Laboratoire des maladies neurodégénératives : mécanismes, thérapies, imagerie (CNRS/CEA/Université Paris-Sud, MIRCen), en collaboration avec l’Ecole normale supérieure, Sorbonne Université et l’Inserm, viennent d’identifier les cibles de ces agrégats. Publiés dans EMBO Journal le 10 janvier 2019, ces travaux permettront la conception d’outils capables de bloquer ces éléments clés dans la propagation des agrégats et de contrecarrer ainsi leur effet pathologique.
-
Press releases - 04.01.2019
Gilles Bloch, Inserm Chairman and Chief Executive Officer, takes office
Appointed by the French Council of Ministers on November 26, 2018, Gilles Bloch took up his post as Chairman and Chief Executive Officer of Inserm on January 2, 2019.
- 2018
-
Press releases - 19.12.2018
Filming the brain to shed light on sleep
What happens inside our brains when we sleep? To answer this question, French researchers have, for the first time, filmed the entire brain in sleeping rats, thanks to innovative ultrasound imaging technology. They were thus able to closely observe brain function in rodents, particularly during the REM sleep phase. These results were obtained in shared Inserm, ESPCI Paris, CNRS, and Sorbonne University laboratories. Published in Nature Communications, these findings allow this period to be redefined as a brain hypersynchronization phase, characterized by massive peaks in blood flow, particularly in the hippocampus. These new data, which question the role currently ascribed to REM sleep, have yet to be confirmed in humans.